WO2020138475A1 - 無針注射器 - Google Patents
無針注射器 Download PDFInfo
- Publication number
- WO2020138475A1 WO2020138475A1 PCT/JP2019/051555 JP2019051555W WO2020138475A1 WO 2020138475 A1 WO2020138475 A1 WO 2020138475A1 JP 2019051555 W JP2019051555 W JP 2019051555W WO 2020138475 A1 WO2020138475 A1 WO 2020138475A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- switch
- user
- syringe
- housing
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3007—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules with specially designed jet passages at the injector's distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2046—Media being expelled from injector by gas generation, e.g. explosive charge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2485—Ampoule holder connected to rest of syringe
- A61M2005/2488—Ampoule holder connected to rest of syringe via rotation, e.g. threads or bayonet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3114—Filling or refilling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
Definitions
- the disclosure of the present application relates to a needleless injector that ejects an injection target substance to a target area without using an injection needle.
- a needleless injector without an injection needle can be exemplified as a device for injecting a drug solution or the like into a target area such as a living body, but in recent years, attention has been paid to its ease of handling and hygiene, and its development has been carried out.
- a chemical solution pressurized by a driving source such as a compressed gas or a spring is ejected toward a target area, and the kinetic energy of the chemical solution is used to eject the chemical solution inside the target area.
- the configuration has been put to practical use.
- Patent Document 1 discloses an operating mechanism for the safe use of a needleless injector. Due to the characteristics of the needle-free injector, the drug solution is vigorously ejected to the outside. Therefore, it is not preferable that the needle-free injector is inadvertently operated and the drug solution is ejected. Therefore, the needle-free injector of Patent Document 1 has a switch for operating the igniter on the side surface of the housing of the needle-free injector, and a standby switch protruding from the front end surface of the housing. The standby switch is formed in a protruding state by being biased by a spring inside the housing.
- the standby switch is pushed into the inside by the switch for standby, and the switch for igniter operation is activated. It is activated.
- a needleless syringe in the use of a needleless syringe, its outlet is in a predetermined state with respect to the target area (for example, the state where the outlet is in contact with the target area, the state where the outlet is opposed to the target area, etc.). ), it is expected that the injected chemical solution will behave as designed inside the target area. Therefore, in the conventional technique, in order to avoid the igniter from operating in a state where the injection port of the needle-free injector does not come into contact with the target area, a standby switch is provided in addition to the switch for operating the igniter. ing. By thus duplicating the operating mechanism of the needleless injector, its safety is improved.
- the operation of the needleless syringe by the user and the state of the target area are not always constant. There may be individual differences in how the housing of the needleless syringe hits the target area, or differences in the reaction force received by the standby switch from the target area due to differences in elasticity of the target area. Therefore, even if the user operates the needleless syringe so that the injection port comes into contact with the target area in order to push the switch for standby inside and put the needleless syringe in the standby state, the standby state is preferably formed. Without this, stable operation of the needleless syringe may be hindered.
- the present disclosure aims to provide a needle-less injector operating mechanism capable of realizing both improved safety and stable operation.
- the present disclosure is a needle-free injector that ejects an injection target substance into a target region without passing through an injection needle, and has a storage space in which the injection target substance is stored and the injection target substance is An accommodating part that defines a flow path so as to be ejected to a target region, a drive part that imparts ejection energy for ejecting the injection target substance, and the accommodating space by imparting the ejection energy.
- the first switch is a side surface of the front surface of the syringe housing that is located on the user side, and is in a first region covered by the palm of the user in a gripped state by the user, in the contact direction of the palm of the user. Is slidably arranged in a different predetermined direction, and the second switch is partly user-visible so that at least part of the upper surface of the second switch is visible to the user when grasped by the user. It is formed to be tilted to the side and is arranged to be able to be pushed on the upper side of the syringe housing.
- the drive unit applies injection energy in order to eject the injection target substance to the target area.
- “Injection” in the present application is realized by pressurizing the injection target substance in the storage unit by the pressurizing unit using the injection energy from the drive unit, so that the injection target substance flows through the flow path of the storage unit.
- the injection target substance injected by the needleless syringe a predetermined substance containing a component expected to be effective in the target region or a component expected to exhibit a predetermined function in the target region can be exemplified. Therefore, the physical form of the injection target substance does not matter as long as the injection energy can be emitted at least.
- the substance to be injected may exist in a state of being dissolved in the liquid, or may be simply mixed without being dissolved in the liquid.
- the predetermined substances to be delivered include vaccines for antibody enhancement, proteins for beauty treatment, cultured cells for hair regeneration, etc., and these should be contained in a liquid medium so that they can be ejected.
- a target substance for injection is formed.
- the medium is preferably a medium that does not impair the above-mentioned efficacy or function of the predetermined substance when injected into the target region.
- the medium may be a medium that exerts the above-mentioned effects and functions by acting together with a predetermined substance in a state of being injected into the target region.
- the drive unit applies the injection energy by using a combustion product released by the combustion of the ignition charge.
- explosive containing bismuth oxide, explosive containing aluminum and molybdenum oxide, explosive containing aluminum and copper oxide, explosive containing any one of explosives containing aluminum and iron oxide, or explosive consisting of a plurality of combinations thereof Can be adopted.
- the drive unit may use electric energy such as a piezoelectric element or mechanical energy such as a spring as the ejection energy instead of the ejection energy due to the combustion of the ignition charge, and the energy of these forms may be appropriately combined.
- the injection energy may be generated at.
- a syringe housing formed so that a user can hold the needleless syringe with one hand when using the needleless syringe is provided with a first switch and a second switch for operating the needleless syringe.
- the control unit judges the operation content of each switch and the operation suitable for the operation of the needleless syringe is executed, the control unit operates the drive unit and the injection of the injection target substance by the needleless injector is executed. It will be.
- the first switch and the second switch are arranged at different positions, and the operation contents required for operating the needleless syringe are different.
- the first switch is a slide type switch and is arranged in the first region on the side surface of the syringe housing.
- the first region is a region covered by the palm of the user when the user tries to hold the syringe housing with one hand. Therefore, when the user holds the syringe housing, the palm comes into contact with the first switch so as to cover it from above, but the contact direction, that is, the direction in which the palm approaches the first switch, slides. This is a direction different from the slide direction, which is the operation direction of the first switch of the formula.
- the user in order to allow the user to slide the first switch, as an example, the user temporarily holds a part of the palm so that the other finger can be accessed while the user holds one finger on the syringe housing. Need to be separated from the area.
- the second switch is a push-down switch and is placed above the syringe housing. Then, at least a part of the upper surface of the second switch is formed so as to be inclined toward the user. At least a part of the upper surface of the second switch is a part that can be a pressing part, and the pressing part is formed as described above, so that the user holding the syringe housing with one hand can operate the second switch. It becomes easier to visually recognize the pressed part of.
- Such a configuration allows the user to clearly recognize the presence of the second switch, which is a push-down switch, and leads to stable operation of the needleless syringe.
- the method of gripping the syringe housing by the user is also specified and gripping with good reproducibility is possible, so that stable injection is realized.
- the user's operation contents for the first switch and the second switch configured as described above are input to the control unit, and the suitability thereof is determined to control the operation of the drive unit. Therefore, the safety of the needleless syringe is improved by the above-mentioned configuration in which the two switches that require different operation contents are arranged at different positions and the operation contents are duplicated, and the suitable operation of the first switch and the second switch is ensured. It is possible to realize both improvement of the property and stable operation.
- the second switch is provided on the upper surface of the syringe housing that is configured to be inclined toward the user side at least similarly to at least a part of the upper surface of the second switch. It may be arranged in the second region.
- the second switch is a virtual one in which the slide straight line of the first switch along the predetermined direction extends along the surface of the syringe housing in the second region. It may be arranged on a straight line, or may be arranged near the virtual straight line. With such a configuration, for a user who holds the syringe housing with one hand, for example, the sliding operation for the first switch and the pressing operation for the second switch, which are performed with the fingers of the one hand, can be smoothly continued. .. This greatly contributes to the improvement of the operability of the needleless injector by the user.
- the slide straight line is a straight line defined by the sliding direction of the first switch that is a slide type.
- the control unit operates the drive unit starting from a predetermined pressing operation of the second switch, which is performed after a predetermined slide operation of the first switch by the user. It may be configured to allow. That is, the control unit permits the operation of the drive unit when a predetermined slide operation is performed on the first switch and then a predetermined pressing operation is performed on the second switch.
- the predetermined slide operation is, so to speak, an operation of placing the needleless syringe in the state where the injection preparation is completed (standby state), and the predetermined pressing operation executes the injection of the injection target substance in the needleless syringe in the standby state. It becomes the action to do.
- the user can sequentially perform the operations for executing the injection while accurately grasping the situation where the needle-free injector is placed, and it is possible to suitably prevent the erroneous operation by the user.
- the operations of the first switch and the second switch for permitting the operation of the drive unit may be operations other than the above operations.
- the predetermined slide operation may be an operation of sliding the first switch in a predetermined direction and maintaining the sliding state for a predetermined time.
- requiring the user to hold the slide state for a predetermined time means that the user operates the needleless syringe with a clear intention, Therefore, it is possible to avoid accidentally ejecting the injection target substance by accidentally placing the needleless injector in the standby state, and it is possible to maintain high safety.
- the predetermined time can be appropriately determined in consideration of the balance between the operability of the needleless syringe by the user and ensuring safety.
- the drive unit is an ignition device that burns an ignition charge to generate the injection energy by being supplied with an ignition current, and the ignition is performed from a power supply from the injector housing.
- a power supply cable for supplying an ignition current to the device extends, and the syringe housing extends in a direction in which the power supply cable separates from the user when the user holds the first switch so that the first switch faces the user. May be configured to exit. That is, since the ignition device is an electric igniter, it is necessary to supply an ignition current to the ignition device in order to apply the injection energy.
- the power cable extends from the syringe housing, but at this time, the movement of the needle-free injector is restricted by the power cable. It will be in the state of being. Therefore, for the user, the operability of the needleless syringe will be impaired by the power cable, but the influence of the power cable can be affected by setting the extension direction of the power cable away from the user as described above. It can be reduced as much as possible.
- a connector to which the power cable is connected is provided on a side surface of the syringe housing opposite to the first switch across the second switch,
- the connector is attached to the syringe housing such that the power cable extends along an inclined surface formed by at least a portion of an upper surface of the second switch.
- FIG. 9 is a second cross-sectional view of the needleless syringe. It is a figure which shows the structure of the housing of a needleless syringe. It is a figure which shows schematic structure of the syringe assembly incorporated in a needleless syringe. It is a figure which shows schematic structure of the actuator incorporated in a needleless syringe. It is a figure which shows schematic structure of the piston incorporated in a needleless syringe. It is a figure which shows schematic structure of the attachment incorporated in a needleless syringe.
- the injector 1 uses a combustion energy of explosives to eject an injection liquid corresponding to an injection target substance of the present application into a target area, that is, an injection liquid is injected into a target area without passing through an injection needle. This is a device for performing injection.
- distal end side and proximal end side are used as terms that represent the relative positional relationship in the longitudinal direction of the syringe 1.
- the “distal end side” represents a position closer to the distal end of the syringe 1 described later, that is, a position closer to the injection port 77, and the “proximal end side” is a direction opposite to the “distal end side” in the longitudinal direction of the syringe 1, That is, it represents the direction of the igniter 22 side in the syringe assembly 10 (see FIG. 5 described later).
- FIG. 1 is a diagram schematically showing the external appearance of the syringe 1.
- FIG. 2 is a first cross-sectional view of the syringe 1, and the cross section is an AA cross section in FIG. 4 described later.
- 3 is a second cross-sectional view of the syringe 1, the cross section of which is a BB cross section in FIG. 4 described later, and the BB cross section is orthogonal to the AA cross section.
- FIG. 4 is a diagram showing the configuration of the housing 2 that constitutes the syringe 1.
- the syringe 1 is formed by attaching the syringe assembly 10 to the housing 2 (syringe housing).
- a power cable 3 for supplying drive current to the igniter 22 in the syringe assembly 10.
- the injection liquid ejected to the target region by the syringe 1 is formed by containing a predetermined substance that exhibits the expected efficacy and function in the target region in a liquid medium. ing.
- the predetermined substance may be in a state of being dissolved in the liquid that is the medium, or may be in a state of being simply mixed without being dissolved.
- the predetermined substance contained in the ejection liquid examples include a bio-derived substance that can be ejected to a target region that is a living body and a substance that exhibits a desired physiological activity.
- Antibodies, cells, etc., and substances that exert physiological activity include low molecular weight compounds, drugs such as proteins and peptides, vaccines, inorganic substances such as metal particles for hyperthermia and radiation therapy, carriers that serve as carriers. Examples thereof include substances having various pharmacological and therapeutic effects including
- the liquid that is the medium of the ejected liquid may be any substance suitable for administering these predetermined substances into the target region, and may be aqueous or oily.
- the viscosity of the liquid that is the medium is not particularly limited as long as the predetermined substance can be injected by the syringe 1.
- the syringe assembly 10 is configured to be detachable from the housing 2.
- the storage space 75 (see FIG. 5) formed between the container 70 and the plunger 80 included in the syringe assembly 10 is filled with the injection liquid in a preparatory step before the operation of the syringe 1, and the syringe is
- the assembly 10 is a unit that is replaced each time the injection liquid is injected. Details of the syringe assembly 10 will be described later.
- the housing 2 is formed with a grip portion 2a that the user of the syringe 1 holds for use thereof, and is provided with a plurality of switches for operating the syringe 1 to realize injection of the injection liquid. ..
- the syringe 1 is configured such that the user can hold it with one hand and operate it. Therefore, the housing 2 will be described with reference to FIG. In FIG. 4, (a) shows the appearance of the housing 2 when viewed from the front, (b) shows the appearance when the housing 2 is viewed from the side, and (c) shows the housing 2. The external appearance when viewed from the rear is shown, and (d) shows the external appearance when the housing 2 is viewed from above.
- the “front” is a portion located at the distal end of the user when the user holds the housing 2, and is located on the left side in FIG. 4B, and the “rear” is conversely close to the user. It is a part located at the right position in FIG. “Front” and “rear” shown in FIG. 4B correspond to “front” and “rear” shown in FIG. 1, respectively. Therefore, when the user grips the housing 2 with one hand, the fingertip thereof hangs on the front side of the housing 2 on the distal side, and the wrist is in a state of being close to the rear side of the housing 2 on the proximal side.
- the “upper side” is a site on the proximal end side of the syringe 1.
- a grip portion 2a is provided near the front of the housing 2 so that the user's fingertip can easily be caught.
- a plurality of dimples are formed on the grip portion 2a to improve the hooking of the user's fingertip.
- the outer contour on the front side of the grip portion 2a is gently formed (see FIG. 4B), and the index finger and the middle finger of the user are easily caught. There is.
- the housing 2 is provided with two operation switches for operating the syringe 1, a first switch 5 and a second switch 6.
- the first switch 5 and the second switch 6 are connected to a control unit 90 formed by a microcomputer, and the control unit 90 controls the supply of the ignition current to the igniter 22 based on the signal sent from each switch.
- the operation control of the syringe 1 is performed.
- the first switch 5 is a slide type switch provided in the first region R1 on the rear side surface of the housing 2, and the sliding direction thereof is the vertical direction of the housing 2 (the direction connecting the front end and the base end). Which is the direction indicated by the white arrow in FIG. 4C).
- the first region R1 is a region covered by the palm of the user (a portion near the base of the thumb) when the user tries to grip the housing 2 with one hand. Therefore, when the user grips the housing 2, the palm comes into contact with the first switch 5 so as to cover the first switch 5 from above.
- the contact direction of the palm at this time that is, the direction in which the palm approaches the first switch 5 (the direction indicated by the white arrow in FIG. 1) is the sliding direction (injector) that is the operating direction of the slide-type first switch. Direction toward the tip side of 1).
- the user slides the first switch 5 the user puts a finger (for example, an index finger or a middle finger) on the housing 2 and another finger (for example, a thumb) accesses the first switch 5. It is possible to slide the first switch 5 with the other finger while keeping part of the palm temporarily away from the first region R1 to the extent possible.
- the standby state is a state in which the injection liquid is ready to be ejected in the syringe 1, and the ejection is executed if an additional operation (operation of the second switch 6 described later) is performed by the user. ..
- the first switch 5 configured in this manner is an operation switch for bringing the syringe 1 to the standby state, and when the user grips the palm 1, the contact direction of the palm of the user is made different from the operation direction, so that the user can operate the housing. It is possible to preferably avoid an unintended slide operation being applied to the first switch 5 while gripping the second switch 5.
- the second switch 6 is a push-down switch provided in the second region R2 including the upper inclined surface 2b of the housing 2, and the user can push the second switch 6 inward of the housing 2. ..
- the second region R2 is a region which is exposed without being covered by the palm of the user when the user holds the housing 2.
- the upper surface of the second switch 6 is formed to be inclined toward the user side together with the inclined surface 2b in the second region R2.
- the upper surface of the housing 2 may not be inclined, and the upper surface of the second switch 6 may form an inclined surface.
- the upper surface of the second switch 6 forms an inclined surface in this way, a user holding the housing 2 with one hand can easily recognize the upper surface of the second switch 6, which can be a pressed portion, and The pressing operation of the second switch 6 can be performed in a natural gripping state.
- the upper surface of the second switch 6 is easily visible to the user, and the second switch 6 can be pressed down in a natural gripping state, which allows the user to clearly recognize the presence of the second switch and to operate the syringe 1 by mistake. Stable operation without any problems, leading to reproducible administration.
- the control unit 90 causes the igniter 22 to operate.
- the ignition current is supplied.
- the injection liquid is injected by the syringe 1.
- the second switch 6 can also be regarded as an operation switch that determines the injection of the injection liquid in the syringe 1.
- a sliding straight line defined by the sliding direction of the first switch 5 (corresponding to a straight line extending in the direction of the white arrow shown in FIG. 4C) is virtually along the surface of the housing 2.
- the extended straight line is a virtual straight line L1
- the second switch 6 is arranged on the virtual straight line L1 in the second region R2.
- the first region R1 is a region covered by the palm of the user, while the second region R2 is covered by the palm of the user. There is no area.
- the user firmly grips the housing 2 with the palm after performing the sliding operation of the first switch 5 with a specific finger. While pressing the second switch 6, the pressing operation of the second switch 6 can be continuously and smoothly performed with the same finger. This greatly contributes to the improvement of the operability of the syringe 1 by the user.
- the second switch 6 does not necessarily have to be arranged on the virtual straight line L1, and as long as the second switch 6 can be smoothly pushed down after the first switch 5 is slid, the second switch 6 is It may be arranged near the virtual straight line L1.
- the first switch 5 and the second switch 6 are provided at the central portion in the width direction of the housing 2 shown in FIGS. 4(a) and 4(c). Or in the vicinity thereof.
- a connector 4 to which the power cable 3 is connected is provided in front of the inclined surface 2b on the upper surface of the housing 2.
- the connector 4 is a USB connector
- the power cable 3 is attachable to and detachable from the housing 2.
- the power cable 3 may be a cable that cannot be attached to and detached from the housing 2.
- FIG. 1 shows a state in which the power supply cable 3 is connected to the housing 2 via the connector 4. As described above, in the syringe 1, the power cable 3 extends in the front of the housing 2.
- the user when the user holds the housing 2 of the syringe 1 with one hand, the user is located on the rear side of the housing 2, but the power cable 3 extends from the housing 2 toward the front, that is, the user who is holding the syringe. To extend in a direction away from. Therefore, the user can smoothly proceed with the operation of the syringe 1 without the power cable 3 interfering with the operation of the user who is using the syringe 1.
- the extending direction of the power cable 3 in the vicinity of the connecting portion is substantially along the tilt direction of the inclined surface 2 b of the housing 2. It has become a thing. That is, in FIG. 1, the power cable 3 is directed upward in the front direction. With such a configuration, a relatively large space can be secured between the extending power supply cable 3 and the housing 2, so that the power supply cable 3 interferes with the hand of the user holding the housing 2. The degree of can be reduced as much as possible. Needless to say, the extension direction of the power cable 3 may be a direction other than the above-described form, but it is preferable to determine the extension direction in consideration of the degree of interference with the hand of the user.
- the electric power for operating the igniter 22 is supplied from the outside via the power supply cable 3, but instead of this mode, the electric power is supplied to the inside of the housing 2.
- Battery may be provided.
- the housing 2 can be used repeatedly while replacing the syringe assembly 10 as long as there is power remaining in the battery. Then, when the battery power runs out, the battery may be replaced.
- FIG. 10 a schematic configuration of the syringe assembly 10 is shown in FIG.
- the syringe assembly 10 is attached to the housing 2 to form the syringe 1 as shown in FIGS. 2 and 3, and specifically, the syringe assembly 10 includes an actuator 20, an attachment 30, and a container. It is an assembly including 70 and a plunger 80. The assembly of the syringe assembly 10 will be described later.
- the body 20 of the actuator 20 is formed in a tubular shape.
- the body 21 has a central portion 21a at its center, a distal end portion 21b at its distal end side, and a proximal end portion 21c at its proximal end side.
- the distal end portion 21b, the central portion 21a, and the proximal end portion 21c communicate with each other, and an opening 27 is provided on the distal end side of the distal end portion 21b.
- an igniter 22 which is an electric igniter for burning the ignition charge 22a to generate energy for injection is attached to the base end portion 21c of the body 21 via a cap 23.
- the igniter 22 has an ignition pin 22b to which an ignition current is supplied from the outside, and the ignition pin 22b is connected to the socket 7 on the housing 2 side when the syringe assembly 10 is attached to the housing 2. Further, the attachment state of the igniter 22 to the body 21 is determined so that the combustion products generated by the operation of the igniter 22 are discharged to the side of the central portion 21a of the body 21. That is, the igniter 22 is attached to the base end portion 21c of the body 21 so that the discharge surface 22c of the combustion products faces the central portion 21a side.
- the ignition powder is preferably a powder containing zirconium and potassium perchlorate (ZPP), a powder containing titanium hydride and potassium perchlorate (THPP), and a powder containing titanium and potassium perchlorate (TiPP). ), a powder containing aluminum and potassium perchlorate (APP), a powder containing aluminum and bismuth oxide (ABO), a powder containing aluminum and molybdenum oxide (AMO), a powder containing aluminum and copper oxide (ACO), aluminum and Examples include explosives containing iron oxide (AFO), or explosives composed of a plurality of combinations of these explosives.
- ZPP zirconium and potassium perchlorate
- THPP titanium hydride and potassium perchlorate
- TiPP titanium and potassium perchlorate
- APP powder containing aluminum and potassium perchlorate
- ABO aluminum and bismuth oxide
- AMO aluminum and molybdenum oxide
- ACO aluminum and copper oxide
- Examples include explosives containing iron oxide (AFO), or explosive
- the internal space of the central portion 21a of the body 21 where the combustion products are released from the igniter 22 is used as the combustion chamber 20a.
- a male screw portion 26 is formed on a part of the outer surface of the central portion 21a.
- the male screw portion 26 is configured to be screwed with a female screw portion 32 of an attachment 30 described later, and the effective lengths of the male screw portion 26 and the female screw portion 32 are determined so that a necessary coupling force can be secured between them.
- the inner space of the tip portion 21b adjacent to the central portion 21a is formed in a cylindrical shape, and is arranged together with the O-ring 25, which is a sealing member, so that the piston 40 can slide therein.
- the piston 40 is made of metal, has a shaft member 41 as shown in FIG. 7, a first flange 42 is provided on the base end side thereof, and a second flange 43 is further provided near the first flange 42. There is.
- the first flange 42 and the second flange 43 have a disk shape and have the same diameter.
- the O-ring 25 is arranged between the first flange 42 and the second flange 43 and further to the side of the second flange 43.
- a concave portion 44 having a predetermined size is formed on the tip end surface of the shaft member 41.
- the first flange 42 which is the pressure receiving surface due to the combustion products from the igniter 22, is exposed to the combustion chamber 20a side.
- the tip of the shaft member 41 of the piston 40 is inserted into the opening 27.
- the actuator 20 has a mechanism that uses the igniter 22 as an operation source and the piston 40 as an output unit. Since the diameter of the second flange 43 is larger than the diameter of the opening 27, the sliding amount of the piston 40 is limited, so that the shaft member 41 of the piston 40 projects from the tip surface of the tip portion 21b of the body 21. The quantity is also limited. Further, the piston 40 may be made of resin, and in that case, metal may be used together in a portion where heat resistance and pressure resistance are required.
- a gas generating agent that combusts by a combustion product from the igniter 22 to generate gas may be further arranged in the combustion chamber 20a of the actuator 20. The location is where it can be exposed to the combustion products from the igniter 22.
- the gas generating agent may be arranged in the igniter 22, as disclosed in WO 01-031282, JP 2003-25950 A, or the like.
- An example of the gas generating agent is a single base smokeless explosive consisting of 98% by mass of nitrocellulose, 0.8% by mass of diphenylamine and 1.2% by mass of potassium sulfate.
- gas generating agents used in gas generators for airbags and gas generators for seat belt pretensioners. It is possible to change the combustion completion time of the gas generating agent by adjusting the size, size and shape of the gas generating agent, especially the surface shape when the gas generating agent is placed in the combustion chamber 20a or the like. The pressure exerted on 40 can be adjusted to the desired pressure.
- the attachment 30 is a component for mounting the actuator 20, the plunger 80, and the container 70 as shown in FIG.
- the attachment 30 is a component for mounting the actuator 20, the plunger 80, and the container 70 as shown in FIG.
- the body 31 of the attachment 30 for example, known nylon 6-12, polyarylate, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, or the like can be used.
- these resins may contain fillers such as glass fibers and glass fillers, and polybutylene terephthalate contains 20 to 80% by mass of glass fibers, and polyphenylene sulfide contains 20 to 80% by mass of glass fibers.
- the liquid crystal polymer may contain 20 to 80% by mass of minerals.
- the first region 33 from the base end side to the center of the internal space of the body 31 is a region where the actuator 20 is arranged as shown in FIG. Then, the base end portion 21c of the actuator 20 is generally located in the region 33a on the base end side of the first region 33, and the region 33b having a smaller diameter than the region 33a on the tip end side of the first region 33 is generally The central portion 21a and the tip portion 21b of the actuator 20 are located. Further, the female screw portion 32 is arranged on the inner wall surface of the region near the region 33a in the region 33b, and the female screw portion 32 is screwed with the male screw portion 26 provided in the central portion 21a of the actuator 20 as described above. Is formed.
- the second region 34 is formed in communication with the first region 33.
- the second region 34 is a region in which the plunger 80 is generally arranged as shown in FIG. 5, and is a hollow region formed in a cylindrical shape along the axial direction of the body 31.
- One end of the second region 34 communicates with the region 33b of the first region 33.
- the diameter of the second region 34 is smaller than the diameter of the region 33b so that the plunger 80 can slide.
- the body 31 is formed with a through hole 37 penetrating from the lateral outer surface of the attachment 30 to the second region 34. Through this through hole 37, the user can externally confirm the condition of the plunger 80 in the syringe assembly 10 (for example, before or after the operation of the syringe assembly 10) (see FIG. 1 ).
- a third region 35 is formed in communication with the second region 34.
- the third region 35 is a region in which a part of the container 70 is arranged, as shown in FIG. 5, one end of which communicates with the second region 34 and the other end of which opens to the tip surface of the attachment 30. ..
- a female screw portion 36 for attaching the container 70 is formed in the third region 35.
- the female threaded portion 36 is screwed with a male threaded portion 74 of the container 70 shown in FIG. 10 to be described later, so that the attachment 30 and the container 70 are coupled.
- FIG. 9A is an external view of the plunger rod 50, which is one of the members forming the plunger 80
- FIG. 9B is an external view of the plunger 80.
- the plunger 80 is a member that pressurizes the injection liquid by the energy received from the piston 40, and for the plunger rod 50, a resin material suitable for pressurizing the same, for example, the same resin material as the attachment 30 can be used.
- the plunger rod 50 has a shaft member 51, and a protrusion 54 is formed on the end face on the base end side thereof.
- the protrusion 54 is shaped and sized to allow it to fit into the recess 44 of the shaft member of the piston 40 included in the actuator 20 when the plunger 80 is incorporated into the syringe assembly 10. It Further, a reduced diameter portion 52 having a diameter reduced from the diameter of the other shaft member 51 is provided at a portion near the base end in the middle of the shaft member 51.
- a projection 56 is provided on the tip end side of the shaft member 51 via a neck 55 having a diameter smaller than that of the shaft member 51.
- the diameter of the protrusion 56 is larger than the diameter of the neck 55 near the connection portion with the neck 55, but is formed in a cone shape so that the diameter becomes smaller toward the tip side.
- the maximum diameter of the protrusion 56 is also smaller than the diameter of the shaft member 51.
- a plunger 80 is formed by attaching a stopper portion 60 formed of an elastic member such as rubber to the neck portion 55 and the protrusion portion 56 (see FIG. 9B).
- An attachment hole (not shown) is formed in the stopper portion 60, and the attachment portion and the neck portion 55 and the protrusion portion 56 are engaged with each other, so that the stopper portion 60 does not easily come off from the plunger rod 50.
- the stopper portion 60 for example, butyl rubber or silicone rubber can be adopted.
- styrene-based elastomers, hydrogenated styrene-based elastomers, and polyolefins such as polyethylene, polypropylene, polybutene, ⁇ -olefin copolymers, oils such as process oils, process oils, etc., powders of talc, casts, mica, etc. It may be a mixture of inorganic substances.
- various rubber materials such as polyvinyl chloride elastomer, olefin elastomer, polyester elastomer, polyamide elastomer, polyurethane elastomer and natural rubber, isoprene rubber, chloroprene rubber, nitrile-butadiene rubber, styrene-butadiene rubber (especially (Sulfurized) or a mixture thereof may be used as the material of the stopper portion 60. Further, since the stopper portion 60 pressurizes the injection liquid while sliding in the container 70 described later, the slidability between the stopper portion 60 and the inner wall surface 75a of the accommodation space 75 of the container 70 is secured and adjusted.
- the surface of the stopper portion 60 and the inner wall surface 75a of the container 70 may be coated and surface-treated with various substances.
- the coating agent PTFE (polytetrafluoroethylene), silicon oil, diamond-like carbon, nanodiamond or the like can be used.
- FIG. 10A is a sectional view of the container 70
- FIG. 10B is an external view of the container 70.
- the container 70 is a member that stores the injection liquid that is pressurized by the plunger 80, and is a member that defines a flow path for ejecting the injection liquid that is pressurized to the target region.
- the resin material forming the container 70 can be adopted, and for example, the same resin material as the attachment 30 can be used.
- the container 70 is a space that can store the injection liquid, and has a storage space 75 in which the stopper portion 60 of the plunger 80 can be propelled, and a nozzle portion that includes a flow path 76 that connects the storage space 75 and the outside of the container 70. 71 and.
- the outer periphery on the tip side of the nozzle portion 71 is formed in a columnar shape.
- the plunger 80 and the container 70 are arranged so that the stopper portion 60 of the plunger 80 can slide in the accommodation space 75 toward the nozzle portion 71 (toward the distal end side). The relative position of is determined.
- the space formed between the stopper portion 60 of the plunger 80 and the container 70 becomes the space in which the injection liquid is sealed.
- the flow path of the container 70 is opened to the tip surface 73 of the nozzle portion 71, and the injection port 77 is formed. Therefore, when the plunger 80 slides in the accommodation space 75, the injection liquid accommodated in the accommodation space 75 is pressurized and is ejected from the ejection port 77 through the flow path 76.
- the inner diameter of the flow path 76 provided in the container 70 is formed to be smaller than the inner diameter of the accommodation space 75. With such a configuration, the high-pressure injection liquid is ejected from the ejection port 77 to the outside.
- a male screw portion 74 for attaching the container 70 to the attachment 30 is formed on the base end side of the container 70. The male screw portion 74 is screwed with the female screw portion 36 of the attachment 30.
- the contour of the plunger 80 on the front end side of the stopper portion 60 has a shape that substantially matches the contour of the inner wall surface 75a in the vicinity of the portion (the innermost portion of the accommodation space 75) where the accommodation space 75 and the flow path 76 are connected. ing.
- the gap formed between the stopper portion 60 and the inner wall surface 75a of the container 70 is minimized. It can be made extremely small, and it is possible to prevent the injection liquid from remaining in the accommodation space 75 and being wasted.
- the shape of the stopper portion 60 is not limited to a particular shape as long as the desired effect can be obtained in the syringe 1 of the present embodiment.
- the assembly of the syringe assembly 10 will be described.
- the stopper portion 60 of the plunger 80 inserted into the accommodation space 75 of the container 70 to the innermost position, the injection port 77 of the container 70 is communicated with the injection liquid, and the plunger 80 is pulled back. Since the stopper portion 60 and the inner wall surface 75a of the accommodation space 75 are preferably in close contact with each other, a negative pressure is generated in the accommodation space by the pullback operation, and the ejection space 77 is filled with the injection liquid. be able to.
- the actuator 20 is inserted into the attachment 30 from the first region 33 side.
- the actuator 20 is inserted until the tip surface of the tip portion 21b hits the tip surface 33c (see FIG. 8) of the region 33b of the attachment 30, and at this time, the male screw portion provided in the central portion 21a of the actuator 20.
- the actuator 20 and the attachment 30 are suitably coupled by screwing the female screw portion 26 of the attachment 30 with the female screw portion 32 of the attachment 30.
- the recess 44 of the shaft member 41 of the piston 40 incorporated in the actuator 20 is fitted into the protrusion 54 of the shaft member 51 of the plunger 80, and the plunger 80 moves toward the tip side by the piston 40.
- the fixing force of the piston 40 in the tip end portion 21b of the actuator 20 is such that the piston 40 can slide in the tip end portion 21b sufficiently smoothly depending on the pressure received from the combustion products of the igniter 22. Moreover, when the syringe assembly 10 is assembled, the piston 40 is sufficiently resistant to the force received from the plunger 80, and the position of the piston 40 does not change. Alternatively, as shown in FIG. 6, the position where the piston 40 should be positioned so that the top surface of the first flange 42 of the piston 40 faces the combustion chamber 20a of the actuator 20 and is not displaced toward the combustion chamber 20a. You may form a stopper in.
- the plunger 80 is pushed forward from the piston 40 toward the tip side, and the plunger 80 is pushed inside the container 70. Are positioned in place. It should be noted that a part of the injection liquid is discharged from the injection port 77 in response to the pushing of the plunger 80.
- the formation of the syringe assembly 10 is completed.
- the position of the stopper portion 60 of the plunger 80 in the accommodation space 75 of the container 70 is mechanically determined. Since the final position of the stopper portion 60 is a position that is uniquely determined in the syringe assembly 10, the amount of the injection liquid that is finally stored in the storage space 75 in the syringe assembly 10, that is, the injection liquid is injected.
- the amount of the ejected liquid can be set to a predetermined amount.
- the ignition pin 22b of the igniter 22 is fitted into the socket 7 on the housing 2 side and loaded into the housing 2 to prepare the usable syringe 1 (FIGS. 1 to 1). See 3). Then, an operation procedure for ejecting the ejected liquid by the syringe 1 in the usable state will be described based on FIG. 11.
- the user holds the housing 2 of the syringe 1 with one hand (process of S101). At this time, the user's fingertip is in a state of hanging on the front of the housing 2 and holding the grip portion 2a.
- the control unit 90 determines whether or not the sliding state of the first switch has continued for a predetermined time (for example, 3 seconds), and if an affirmative determination is made, the process proceeds to S104, and a negative determination is made. Then, the process after S102 is performed again without shifting to the standby state.
- the control unit 90 puts the syringe 1 in a standby state.
- the syringe 1 may give a predetermined notification by voice or an indicator using an LED so that the user can recognize the standby state of the syringe 1.
- the user presses the second switch 6 with the ejection port 77 in contact with the target area (processing of S105).
- the igniter 22 operates, the injection liquid is pressurized through the piston 40 and the plunger 80, the injection is executed, and the injection liquid is injected into the target area (processing of S106). ..
- Syringe 2 Housing 2a: Grip part 3: Power cable 4: Connector 5: First switch 6: Second switch 10: Syringe assembly 20: Actuator 21: Body 22: Igniter 30: Attachment 31: Body 40: Piston 50: Plunger rod 51: Shaft member 52: Reduced diameter part 60: Stopper part 70: Container 71: Nozzle part 75: Storage space 76: Flow path 77: Injection port 80: Plunger 90: Control part
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
ここで、図1は、注射器1の外観を概的に示す図である。図2は注射器1の第1の断面図であり、その断面は、後述の図4におけるAA断面である。また、図3は注射器1の第2の断面図であり、その断面は、後述の図4におけるBB断面であり、BB断面はAA断面に直交する。なお、図4は注射器1を構成するハウジング2の構成を示す図であることに留意する。ここで、注射器1は、ハウジング2(注射器筐体)に注射器アセンブリ10が取り付けられて形成される。また、ハウジング2には、注射器アセンブリ10内の点火器22に駆動電流を供給するための電源ケーブル3が接続される。
2 :ハウジング
2a :グリップ部
3 :電源ケーブル
4 :コネクタ
5 :第1スイッチ
6 :第2スイッチ
10 :注射器アセンブリ
20 :アクチュエータ
21 :ボディ
22 :点火器
30 :アタッチメント
31 :ボディ
40 :ピストン
50 :プランジャロッド
51 :軸部材
52 :縮径部
60 :ストッパ部
70 :コンテナ
71 :ノズル部
75 :収容空間
76 :流路
77 :射出口
80 :プランジャ
90 :制御部
Claims (8)
- 注射針を介することなく注射目的物質を対象領域に射出する無針注射器であって、
前記注射目的物質が収容される収容空間を有するとともに該注射目的物質が前記対象領域に対して射出されるように流路を画定する収容部と、
前記注射目的物質を射出するための射出エネルギーを付与する駆動部と、
前記射出エネルギーが付与されることで、前記収容空間に収容されている前記注射目的物質を加圧する加圧部と、
前記収容部、前記駆動部、前記加圧部のうち少なくとも何れかを内部に収容し且つ前記ユーザの片手により把持可能に構成された筒状の注射器筐体と、
前記注射器筐体に設けられた、前記駆動部を作動させるための第1スイッチ及び第2スイッチと、
前記第1スイッチ及び前記第2スイッチの予め決定された動作を介して、前記駆動部の作動を制御する制御部と、
を備え、
前記第1スイッチは、前記注射器筐体の表面のうちユーザ側に位置する側面であってユーザによる把持状態で該ユーザの掌で覆われる第1領域において、該ユーザの掌の接触方向とは異なる所定方向にスライド可能に配置され、
前記第2スイッチは、ユーザによる把持状態で該第2スイッチの上側の表面の少なくとも一部がユーザにより視認可能となるように該一部がユーザ側に傾いて形成され、且つ前記注射器筐体の上側に押下可能に配置される、
無針注射器。 - 前記第2スイッチは、該第2スイッチの上側の表面の少なくとも一部と同じようにユーザ側に傾いて構成された、前記注射器筐体の上側の表面における第2領域に配置される、
請求項1に記載の無針注射器。 - 前記第2スイッチは、前記第2領域において、前記所定方向に沿った前記第1スイッチのスライド直線を前記注射器筐体の表面に沿って延在させた仮想直線上に配置され、又は、該仮想直線の近傍に配置される、
請求項2に記載の無針注射器。 - 前記制御部は、ユーザによる前記第1スイッチの所定のスライド操作の後に行われる、前記第2スイッチの所定の押下操作を起点として、前記駆動部を作動させるように構成される、
請求項1から請求項3の何れか1項に記載の無針注射器。 - 前記所定のスライド操作は、前記第1スイッチを所定方向にスライドさせ、且つ、そのスライド状態を所定時間保持する操作である、
請求項4に記載の無針注射器。 - 前記駆動部は、着火電流が供給されることで点火薬を燃焼させて前記射出エネルギーを生成する点火装置であって、
前記注射器筐体からは、電源から前記点火装置への着火電流を供給するための電源ケーブルが延出し、
前記注射器筐体は、ユーザによる前記第1スイッチがユーザ側に向くような把持状態において、前記電源ケーブルがユーザから離間する方向に延出するように構成された、
請求項1から請求項5の何れか1項に記載の無針注射器。 - 前記注射器筐体には、前記電源ケーブルが接続されるコネクタが、前記第2スイッチを挟んで前記第1スイッチとは反対側の、前記注射器筐体の側面に設けられ、
前記コネクタは、前記電源ケーブルが、前記第2スイッチの上側の表面の少なくとも一部による傾斜面に沿って延出するように前記注射器筐体に取り付けられる、
請求項6に記載の無針注射器。 - 前記コネクタは、前記電源ケーブルとの脱着を可能とするように構成される、
請求項7に記載の無針注射器。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201980086466.9A CN113226406B (zh) | 2018-12-27 | 2019-12-27 | 无针注射器 |
| JP2020562536A JP7119121B2 (ja) | 2018-12-27 | 2019-12-27 | 無針注射器 |
| EP19906350.4A EP3903859B1 (en) | 2018-12-27 | 2019-12-27 | Needleless injector |
| US17/418,335 US20220062555A1 (en) | 2018-12-27 | 2019-12-27 | Needleless injector |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-245623 | 2018-12-27 | ||
| JP2018245623 | 2018-12-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2020138475A1 true WO2020138475A1 (ja) | 2020-07-02 |
Family
ID=71127124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2019/051555 Ceased WO2020138475A1 (ja) | 2018-12-27 | 2019-12-27 | 無針注射器 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220062555A1 (ja) |
| EP (1) | EP3903859B1 (ja) |
| JP (1) | JP7119121B2 (ja) |
| CN (1) | CN113226406B (ja) |
| WO (1) | WO2020138475A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022083772A (ja) * | 2020-11-25 | 2022-06-06 | 株式会社ダイセル | 無針注射器 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD931439S1 (en) * | 2018-11-26 | 2021-09-21 | Daicel Corporation | Control unit for needleless injector |
| CN118557842A (zh) * | 2019-01-25 | 2024-08-30 | 株式会社大赛璐 | 耐裂纹性构件 |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6193698B1 (en) * | 1997-07-18 | 2001-02-27 | Disetronic Licensing Ag | System for locking a dosing button in a device for the adminstration of a product to be injected |
| WO2001031282A1 (en) | 1999-10-28 | 2001-05-03 | Daicel Chemical Industries, Ltd. | Electric type initiator and pretensioner |
| JP2003025950A (ja) | 2001-07-19 | 2003-01-29 | Nippon Kayaku Co Ltd | ガス発生器 |
| JP2003310758A (ja) * | 2002-04-15 | 2003-11-05 | Avant Drug Delivery Systems Inc | 遵守および投与量監視プログラムに使用されるデータ記録システムを有するジェット式注射器 |
| JP2004521681A (ja) * | 2000-12-22 | 2004-07-22 | ディーシーエー デザイン インターナショナル リミテッド | 電子制御ユニットを具備するペン型注入装置 |
| WO2015067747A1 (en) * | 2013-11-07 | 2015-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus with language reset feature and method for controlling such an apparatus |
| JP2015150401A (ja) | 2014-02-19 | 2015-08-24 | 株式会社ダイセル | 無針注射器 |
| JP2016198328A (ja) * | 2015-04-10 | 2016-12-01 | 株式会社ダイセル | 注射器 |
| JP2017023813A (ja) * | 2011-04-20 | 2017-02-02 | アムゲン・インコーポレーテッド | 自動式注射装置 |
| US20180056002A1 (en) * | 2016-08-31 | 2018-03-01 | Liang-Chi Shen | Pneumatic needle-free injection device |
| WO2018093622A1 (en) * | 2016-11-15 | 2018-05-24 | Eli Lilly And Company | Medication delivery device with mechanical locking system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2506901A1 (en) * | 2009-12-02 | 2012-10-10 | Sanofi-Aventis Deutschland GmbH | Drive mechanism for drug delivery devices |
| CA2921927A1 (en) * | 2013-08-19 | 2015-02-26 | Dr. Reddy's Laboratories, Ltd. | Selectable single dose auto-injector and methods of making and using same |
| CN105705183A (zh) * | 2013-11-12 | 2016-06-22 | 诺和诺德股份有限公司 | 具有可移动针安装件的药物输送装置 |
| WO2015171964A1 (en) * | 2014-05-07 | 2015-11-12 | Sri International | Needle free injection device |
| CN107921215B (zh) * | 2015-08-18 | 2020-11-17 | 株式会社大赛璐 | 无针注射器 |
| EP3490638A4 (en) * | 2016-07-29 | 2020-01-22 | Alcyone Lifesciences, Inc. | AUTOMATED DRUG DELIVERY SYSTEMS AND METHODS |
| DE102018127795A1 (de) * | 2018-11-07 | 2020-05-07 | Jutta Bode | Elektrisches Handgerät zum Einbringen von kosmetischen Präparaten in die Haut |
-
2019
- 2019-12-27 CN CN201980086466.9A patent/CN113226406B/zh active Active
- 2019-12-27 WO PCT/JP2019/051555 patent/WO2020138475A1/ja not_active Ceased
- 2019-12-27 EP EP19906350.4A patent/EP3903859B1/en active Active
- 2019-12-27 US US17/418,335 patent/US20220062555A1/en active Pending
- 2019-12-27 JP JP2020562536A patent/JP7119121B2/ja active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6193698B1 (en) * | 1997-07-18 | 2001-02-27 | Disetronic Licensing Ag | System for locking a dosing button in a device for the adminstration of a product to be injected |
| WO2001031282A1 (en) | 1999-10-28 | 2001-05-03 | Daicel Chemical Industries, Ltd. | Electric type initiator and pretensioner |
| JP2004521681A (ja) * | 2000-12-22 | 2004-07-22 | ディーシーエー デザイン インターナショナル リミテッド | 電子制御ユニットを具備するペン型注入装置 |
| JP2003025950A (ja) | 2001-07-19 | 2003-01-29 | Nippon Kayaku Co Ltd | ガス発生器 |
| JP2003310758A (ja) * | 2002-04-15 | 2003-11-05 | Avant Drug Delivery Systems Inc | 遵守および投与量監視プログラムに使用されるデータ記録システムを有するジェット式注射器 |
| JP2017023813A (ja) * | 2011-04-20 | 2017-02-02 | アムゲン・インコーポレーテッド | 自動式注射装置 |
| WO2015067747A1 (en) * | 2013-11-07 | 2015-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus with language reset feature and method for controlling such an apparatus |
| JP2015150401A (ja) | 2014-02-19 | 2015-08-24 | 株式会社ダイセル | 無針注射器 |
| JP2016198328A (ja) * | 2015-04-10 | 2016-12-01 | 株式会社ダイセル | 注射器 |
| US20180056002A1 (en) * | 2016-08-31 | 2018-03-01 | Liang-Chi Shen | Pneumatic needle-free injection device |
| WO2018093622A1 (en) * | 2016-11-15 | 2018-05-24 | Eli Lilly And Company | Medication delivery device with mechanical locking system |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022083772A (ja) * | 2020-11-25 | 2022-06-06 | 株式会社ダイセル | 無針注射器 |
| JP7516223B2 (ja) | 2020-11-25 | 2024-07-16 | 株式会社ダイセル | 無針注射器 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7119121B2 (ja) | 2022-08-16 |
| EP3903859A4 (en) | 2022-09-14 |
| EP3903859A1 (en) | 2021-11-03 |
| US20220062555A1 (en) | 2022-03-03 |
| CN113226406B (zh) | 2023-11-03 |
| CN113226406A (zh) | 2021-08-06 |
| EP3903859B1 (en) | 2025-09-24 |
| JPWO2020138475A1 (ja) | 2021-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4076593B1 (en) | Spring loaded medical needle-free injection system | |
| JP7119121B2 (ja) | 無針注射器 | |
| CN107921215B (zh) | 无针注射器 | |
| US20220062556A1 (en) | Needleless injector | |
| WO2020138476A1 (ja) | 無針注射器 | |
| JP6955521B2 (ja) | 注射器 | |
| EP3903860B1 (en) | Needleless injector with weakened plunger part | |
| JP6345978B2 (ja) | 無針注射器 | |
| US11992460B2 (en) | Adapter and injection fluid transfer method | |
| JP7516223B2 (ja) | 無針注射器 | |
| WO2025009547A1 (ja) | 位置ずれ防止具及び無針注射器 | |
| WO2025100489A1 (ja) | 無針注射器 | |
| WO2025018415A1 (ja) | 硝子体内投与用具及び無針注射器 | |
| WO2021246061A1 (ja) | 無針注射器 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19906350 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2020562536 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2019906350 Country of ref document: EP Effective date: 20210727 |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2019906350 Country of ref document: EP |